Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cannara Biotech Inc. V.LOVE

Alternate Symbol(s):  LOVFF

Healthcare Cannabis
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Company’s brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.


TSXV:LOVE - Post by User

Cannara Biotech Inc. > Lenny gone
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Comment by GordonGecko1986on Nov 05, 2020 9:40pm
196 Views
Post# 31849346

RE:Lenny gone

RE:Lenny gone
Where did you get that? Numbers won't be super good for sure. Sell's pace should not accelerate. So, no big surprise if numbers are bad. 
 
What ever the numbers, they must have the recreational permit. 
( https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/industry-licensees-applicants/licensed-cultivators-processors-sellers.html )
 
Once they have this... may be the price will go back to 0.17$. If sells are good, may be 0.30$. Anyway, sure that they'll invest to the phase 2 automatically. Future demand on cannabis are up and not because Biden will win, Quebec demand are rising 3x since last quarter. Seek for their latest cannabis demand canadian gov projection. 
 
Cannabis stocking is another part of the problem in Canada. It should lowered down soon (like in the next 9 months) based on their projection.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities